Evidence-based articles on PEMF therapy, clinical protocols, and investment insights — updated regularly.
Latest Articles
43% faster return to training vs. rest-only. PEMF directly addresses tibial periosteal remodeling — the mechanism standard care misses. Full protocol and evidence summary for sports medicine and military rehab clinics.
61% of patients reduced or eliminated analgesic use. PEMF suppresses prostaglandin synthesis at the source — drug-free, non-hormonal, and effective from cycle one. The business case for women's health clinics.
40+ years of use, FDA 510(k) cleared, 3,000+ peer-reviewed papers, Grade A evidence across 3 conditions. The complete evidence framework and safety protocol every clinic investor needs before making a decision.
A head-to-head clinical comparison of three pain treatment technologies. Penetration depth, pain reduction data, supervision requirements, and ROI — all in one table.
Step-by-step integration protocol for clinics. Approved indications, staff training, patient scheduling, contraindications, and the financial case — with real data from 60+ Israeli clinics.
36% pain reduction vs. 10% standard care. 55% medication reduction. A 2025 multicenter RCT with 91 patients shows what PEMF actually does for the hardest-to-treat back pain cases.
Stay Updated
New clinical research summaries, protocol guides, market analysis, and investment case studies are published every week. Subscribe to get them directly — or contact us for the full research package.